Aurélie Chantöme

Title: Aurélie Chantöme: Innovator in Glycolipid Research

Introduction

Aurélie Chantöme is a notable inventor based in Tours, France. She has made significant contributions to the field of biochemistry, particularly in the development of glycolipids and their applications in medical treatments. Her work focuses on the modulation of SK3 ion channels, which are crucial in various physiological processes.

Latest Patents

Aurélie Chantöme holds a patent for "Glycolipids and use thereof as SK3 ion channel modulators." This patent describes new glycolipid derivatives of Formula (I) and their potential use in treating diseases associated with the deregulation of SK3 ion channels. Additionally, it includes pharmaceutical compositions that incorporate these compounds for therapeutic applications.

Career Highlights

Throughout her career, Aurélie has worked with esteemed institutions such as Université de Bretagne Occidentale and Université de Tours. Her research has contributed to a deeper understanding of glycolipids and their therapeutic potential, showcasing her expertise in the field.

Collaborations

Aurélie has collaborated with notable colleagues, including Paul Alain Jaffres and Hélène Couthon. These partnerships have enriched her research and expanded the impact of her work in the scientific community.

Conclusion

Aurélie Chantöme's innovative research in glycolipids and their applications in medicine highlights her role as a leading inventor in her field. Her contributions continue to pave the way for advancements in the treatment of diseases related to SK3 ion channels.